TREDJE AP-FONDEN Alnylam Pharmaceuticals, Inc. Transaction History

TREDJE AP-FONDEN portfolio value:

$4.77M
portfolio value

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 23.84K shares 4.77M $200.16 23.84K
Q2 2018 share Decrease -100.00% -7.2K shares -858K $98.49 0
Q1 2018 share Increase +97.26% 3.55K shares 394K $119.1 7.2K
Q4 2017 share Increase 0.00% 3.65K shares 464K $127.05 3.65K